These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11792476)

  • 1. Anterior pituitary adenomas in patients aged more than 65 years: analysis of growth fraction (using the MIB-1 monoclonal antibody) and of clinical features in comparison to younger patients.
    Mastronardi L; Guiducci A; Puzzilli F; Maira G
    Clin Neurol Neurosurg; 2002 Jan; 104(1):44-8. PubMed ID: 11792476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocorticotropic hormone secreting pituitary adenomas: analysis of growth fraction using the MIB-1 antibody.
    Mastronardi L; Guiducci A; Spera C; Puzzilli F; Liberati F; Ruggeri A; Peciarolo A
    Tumori; 2000; 86(3):229-32. PubMed ID: 10939604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody.
    Mastronardi L; Guiducci A; Spera C; Puzzilli F; Liberati F; Maira G
    J Clin Pathol; 1999 Feb; 52(2):107-11. PubMed ID: 10396237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas.
    Mastronardi L; Guiducci A; Puzzilli F
    BMC Cancer; 2001; 1():12. PubMed ID: 11570981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody.
    Pizarro CB; Oliveira MC; Coutinho LB; Ferreira NP
    Braz J Med Biol Res; 2004 Feb; 37(2):235-43. PubMed ID: 14762579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W; Lüdecke B; Lüdecke DK
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and growth fractions of pituitary adenomas.
    Yonezawa K; Tamaki N; Kokunai T
    Surg Neurol; 1997 Nov; 48(5):494-500. PubMed ID: 9352815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and long-term follow-up results.
    Losa M; Franzin A; Mangili F; Terreni MR; Barzaghi R; Veglia F; Mortini P; Giovanelli M
    Neurosurgery; 2000 Dec; 47(6):1313-8; discussion 1318-9. PubMed ID: 11126902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation in pituitary adenomas: measurement by MAb KI 67.
    Kitz K; Knosp E; Koos WT; Korn A
    Acta Neurochir Suppl (Wien); 1991; 53():60-4. PubMed ID: 1803886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas.
    Jaffrain-Rea ML; Di Stefano D; Minniti G; Esposito V; Bultrini A; Ferretti E; Santoro A; Faticanti Scucchi L; Gulino A; Cantore G
    Endocr Relat Cancer; 2002 Jun; 9(2):103-13. PubMed ID: 12121834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mdm2 and the p53 pathway in human pituitary adenomas.
    Suliman M; Royds J; Cullen D; Timperley W; Powell T; Battersby R; Jones TH
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):317-25. PubMed ID: 11298083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical and pathological significance of nitric oxide synthase in human pituitary adenomas: a comparison with MIB-1.
    Onishi K; Kamida T; Momii Y; Abe T; Fujiki M
    Endocrine; 2014 May; 46(1):154-9. PubMed ID: 24008756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of Ki-67 labeling index in pituitary adenomas using MIB-1 monoclonal antibody.
    Lath R; Chacko G; Chandy MJ
    Neurol India; 2001 Jun; 49(2):144-7. PubMed ID: 11447433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labeling index in pituitary adenomas evaluated by means of MIB-1: is there a prognostic role? A critical review.
    de Aguiar PH; Aires R; Laws ER; Isolan GR; Logullo A; Patil C; Katznelson L
    Neurol Res; 2010 Dec; 32(10):1060-71. PubMed ID: 20483025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.
    Wolfsberger S; Wunderer J; Zachenhofer I; Czech T; Böcher-Schwarz HG; Hainfellner J; Knosp E
    Acta Neurochir (Wien); 2004 Aug; 146(8):831-9. PubMed ID: 15254805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index.
    Tanaka Y; Hongo K; Tada T; Sakai K; Kakizawa Y; Kobayashi S
    J Neurosurg; 2003 Feb; 98(2):359-65. PubMed ID: 12593623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas].
    Miyagami M; Nakamura S
    No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody.
    Thapar K; Kovacs K; Scheithauer BW; Stefaneanu L; Horvath E; Pernicone PJ; Murray D; Laws ER
    Neurosurgery; 1996 Jan; 38(1):99-106; discussion 106-7. PubMed ID: 8747957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The relationship between cell proliferation activity and secretory activity in pituitary adenoma--a review of 63 cases].
    Asano K; Kubo O; Tajika Y; Huang MC; Takakura K
    No To Shinkei; 1996 Jun; 48(6):543-9. PubMed ID: 8703557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.